The 1 analysts offering 12-month price forecasts for Cumberland Pharmaceuticals Inc have a median target of 8.50, with a high estimate of 8.50 and a low estimate of 8.50. The median estimate represents a +286.36% increase from the last price of 2.20.
The current consensus among 1 polled investment analysts is to Buy stock in Cumberland Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.01
Reporting Date Mar 08
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.